about
Development of an aptamer-based concentration method for the detection of Trypanosoma cruzi in bloodBiological and Structural Characterization of Trypanosoma cruzi Phosphodiesterase C and Implications for Design of Parasite Selective InhibitorsIn vitro and in vivo investigation of the efficacy of arylimidamide DB1831 and its mesylated salt form--DB1965--against Trypanosoma cruzi infectionRisk Factors and Screening for Trypanosoma cruzi Infection of Dutch Blood DonorsTen-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donorsChallenges and perspectives of Chagas disease: a review.Tropical diseases of the myocardium: a reviewInflammasomes in host response to protozoan parasites.Pathogen-induced proapoptotic phenotype and high CD95 (Fas) expression accompany a suboptimal CD8+ T-cell response: reversal by adenoviral vaccine.Chagas disease awareness among Latin American immigrants living in Los Angeles, California.Are protozoan metacaspases potential parasite killers?Barriers to treatment access for Chagas disease in MexicoPhosphodiesterase inhibitors as a new generation of antiprotozoan drugs: exploiting the benefit of enzymes that are highly conserved between host and parasite.Trypanosoma cruzi evades the protective role of interferon-gamma-signaling in parasite-infected cells.Negativation of Trypanosoma cruzi PCR within Six Months after Treatment of a Child with NifurtimoxAssessment of rectocolonic morphology and function in patients with Chagas disease in Barcelona (Spain).The application of biomedical engineering techniques to the diagnosis and management of tropical diseases: a review.Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-ExpressionChagas heart disease: report on recent developments.Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participationChallenge of chronically infected mice with homologous trypanosoma cruzi parasites enhances the immune response but does not modify cardiopathy: implications for the design of a therapeutic vaccine.Invasion and intracellular survival by protozoan parasites.Apoptotic CD8 T-lymphocytes disable macrophage-mediated immunity to Trypanosoma cruzi infection.Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain.Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospectsNitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage.Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time.Therapy of vector-borne protozoan infections in nonendemic settings.Advances and challenges towards a vaccine against Chagas disease.EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system.The TGF-β pathway as an emerging target for Chagas disease therapy.An approach to the management of Trypanosoma cruzi infection (Chagas' disease) in immunocompromised patients.Diagnosis of parasitic infections: what's going on?Insight into the Exoproteome of the Tissue-Derived Trypomastigote form of Trypanosoma cruzi.Immune responses against protozoan parasites: a focus on the emerging role of Nod-like receptors.Infectious Complications After Liver Transplantation.Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.Lineage-specific serology confirms Brazilian Atlantic forest lion tamarins, Leontopithecus chrysomelas and Leontopithecus rosalia, as reservoir hosts of Trypanosoma cruzi II (TcII).Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
P2860
Q27322870-966C8198-CE22-476C-A948-AC13CF91D498Q27677423-A4B8BD0D-8186-4194-8F5A-C8A14B5524E9Q28479017-20E4AF17-5631-4794-BF06-170960D8775AQ29353622-E607B472-D5AE-4022-8C80-EFFF3F8C4598Q30441765-97450EEC-22FA-4BF1-B72D-E23FFB165867Q30566256-4A2E38E1-8250-406D-84A3-F27B6F0F5C3BQ33563268-FC7C6256-A508-4B7B-8DDF-331D26A87165Q34043775-CA35D87D-D841-4E61-A158-973D9EF6FCBCQ34277020-3FE475D8-CD64-47A7-A20C-A5812583FE5AQ34496192-787E935B-A7E4-4674-9511-275384DC058AQ34677741-BEE690D6-5041-44AD-92B7-D8DA2F02E3B4Q35023674-120ED9C7-06E7-4DAA-BE2C-82B5C9059E59Q35189546-883753CD-F50E-44E4-9B01-C9425D67B90AQ35361340-65332EC9-ADAC-476F-B85E-AF28CD559995Q35581924-A1166391-F4AB-4697-99BE-08473D0D9B68Q35590724-9230DAA7-FF6A-414B-9F48-CD8C06B1689CQ35617736-76E55F41-7AE7-4FBD-8CC9-4AFCC225CB2AQ35652603-E089B07A-5942-4984-BEFC-89A5FAF8BC7AQ35663668-03F95F83-64CE-4F71-8AAE-0FB4E90E185CQ35745413-CC5CA5A3-E029-4EBF-B83A-A90C7AE802BDQ36278397-05137783-A3E7-4DF7-97E0-7AA243960012Q36606779-32F5D742-6BF0-4B07-86F7-7A93431700F8Q36971309-E26DAA28-224E-4881-9AAB-55F10C9A465EQ37030324-3ED7EB35-D785-48D9-BF0B-2BD653E43429Q37119579-0E3EB3D0-7934-4819-97A1-EA700460E607Q37286061-EDCD85EA-C25C-453C-92AD-9B234FA9C47CQ37342932-9A7D5EB9-94C0-40F6-96AD-81070749E7FFQ37613699-7FAD44F2-957E-4206-80EC-D4C82865FFBAQ37879203-50EDE998-AF55-4AA0-AC1E-9D079E037643Q37952062-FB00998F-488E-4780-AFAB-FC872E65A8B3Q38033652-9BAE1A92-B721-49E2-A339-C3C1F753828DQ38044657-28C332E9-1DA0-42B1-B82D-EAE89BA6F6C7Q38183905-465E4783-2EC1-4771-A64C-58D2A928744DQ38244508-A98D2BA2-CC61-4437-A94D-308AD480A9CDQ38440096-7477B9BC-0339-43E7-B676-FDEE212C6D60Q38794791-07591806-610D-4B30-A551-FE7906A2D4E4Q38822708-E0A5C0DB-07FA-4986-972B-6E79835C04A1Q38901429-8C895E14-4189-45DD-835B-B1B7AEE2869AQ39129483-2B63C2B5-CC87-4A0F-8DFD-63ADF0891459Q39355235-583B8057-F1C5-4A87-9668-225094D75C59
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chagas disease: changes in knowledge and management.
@en
Chagas disease: changes in knowledge and management.
@nl
type
label
Chagas disease: changes in knowledge and management.
@en
Chagas disease: changes in knowledge and management.
@nl
prefLabel
Chagas disease: changes in knowledge and management.
@en
Chagas disease: changes in knowledge and management.
@nl
P2093
P1476
Chagas disease: changes in knowledge and management.
@en
P2093
François-Xavier Lescure
Gilles Pialoux
Guillaume Le Loup
Hector Freilij
Laurent Brutus
Michel Develoux
P304
P356
10.1016/S1473-3099(10)70098-0
P5008
P577
2010-08-01T00:00:00Z